Following an emergency appeal by Apple, the latest smartwatches, Series 9 and Ultra 2, are now permitted to resume sales in the United States.
The tech company sought intervention after a patent dispute led to the cessation of sales for these devices.
The U.S. trade body had previously prohibited the import and sale of Apple watches incorporating technology for blood-oxygen level readings, prompted by allegations from device maker Masimo, who accused Apple of both talent and technology poaching.
Despite Apple expressing strong disagreement with the initial ruling, the White House chose not to reverse the ban on sales and imports of the Series 9 and Ultra 2 watches, which took effect recently, the BBC reported.
Subsequently, Apple swiftly filed an emergency appeal with the U.S. Court of Appeals, successfully securing the removal of the sales ban.
Written by B.C. Begley
*The following content has been automatically generated by an AI system and should be used for informational purposes only. Any actions taken based on this content are at your own risk. We recommend seeking qualified expertise or conducting further research to validate and supplement the information provided.
B.C. Begley 